JAMA Study Finds E-Cigarettes, More Than NRTs, Help With Smoking Cessation During Pregnancy
Executive Summary
As authors of JAMA study say theirs and others' research might influence regulatory policy on e-cigarettes’ use in smoking cessation, FDA publishes latest batch of warnings to businesses selling the products without pre-market approval required from the agency.
You may also be interested in...
US Smoking Cessation Options Could Expand Behind Achieve Life’s Cytisinicline Studies
Achieved Life would seek approval as Rx smoking cessation drug, but ingredient has history of safety and efficacy available OTC in other countries, says lead researcher in study published in Journal of the American Medical Association.
US Has Pieces For Solving Policy Puzzle To Spur Spread Of Smoking Cessation Products, Programs
Former FDA tobacco programs chief Mitch Zeller says needed is commitment from White House to require reduction in nicotine levels in tobacco products and movement by FDA on finalizing rules prohibiting use of menthol and other flavors in cigarettes and some cigars.
US Smoking Cessation Clinical Trials Guidance 'Does Not Envision' Flexibility On Indications
FDA final guidance maintains limit on secondary endpoints allowed for trials, which could dissuade some investment in research for NDAs for smoking cessation products. NRT developers could find more room for novel product proposals from changes to some phrasing.